Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil" (Q24673003)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil" (English)

0 references

X-linked adrenoleukodystrophy

1 reference

based on heuristic

inferred from title

author name string

B M van Geel

1

0 references

J Assies

2

0 references

E B Haverkort

3

0 references

J H Koelman

4

0 references

B Verbeeten

5

0 references

R J Wanders

6

0 references

P G Barth

7

0 references

language of work or name

0 references

publication date

September 1999

0 references

Journal of Neurology, Neurosurgery and Psychiatry

0 references

67

0 references

3

0 references

290-9

0 references

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

7 April 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

7 April 2017

Lorenzo's oil and platelet activation in adrenomyeloneuropathy and asymptomatic X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

A mouse model for X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Dietary management of X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Clinical and Therapeutic Aspects of Adrenoleukodystrophy and Adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

The Barthel ADL Index: a standard measure of physical disability?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: phenotypic variability and implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

High dose immunoglobulin IV treatment in adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

19 June 2018

In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Somatosensory evoked potentials, sensory nerve potentials and sensory nerve conduction in hereditary motor and sensory neuropathy type I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Progression of X-linked adrenoleukodystrophy under interferon-beta therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced stimulability of platelet surface adhesion molecules under treatment with Lorenzo's oil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posterior tibial and sural nerve somatosensory evoked potentials: a study in spastic paraparesis and spinal cord lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Synthesis of Hexacosanoic Acid (C26 :0) by Cultured Skin Fibroblasts from Patients with Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN)1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lorenzo's oil and lymphocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin for X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.67.3.290

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24673003&oldid=1951347125"